Blog

With complex oncology studies, mid-study changes are the norm, but disruptions from downstream impacts don’t have to be. Here are 5 supply chain impacts resulting from master protocol amendments– and how to best prepare.

With master protocols, each site has to perform its own approval process in order to begin working under a new protocol version, resulting in multiple protocol versions being used at the same time. How can you manage this? Here are 3 simple steps.

A master protocol acts like a map showing many paths a clinical trial may take, where the sponsors don’t know in which direction their study will evolve, until the trial is under way.

Q&A with a clinical research site discussing COVID-19 and the movement towards Direct-to-Patient trials.

Direct-to-Patient (DtP) trials are more prevalent than ever before. Here are 5 questions to ask yourself when planning a DtP trial.

Hear a patient's perspective on the impact of COVID-19 on immunocompromised clinical trial participants and how industry may be able to help.

In this interview, two senior industry clinical trial supply professionals discuss experiences with manual tools and existing commercial solutions, as well as the need for an improved clinical supply forecasting solution.

Scenario planning is not just comparing two detailed data sets. To be meaningful, it must explore possible outcomes based on a specific combination of events while balancing risks and costs. With so many variables, how do you inform the best strategy? Here is our ultimate guide to scenario planning clinical supply decisions.

Integrations don't need to involve complicated coding to develop. Modern tech can simplify implementation and enable a conversation between systems.